Página 3 - Melhores Tumor adrenal médicos - TOP-66 médicos

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

O Dr. Volkan Kinas é especialista em cirurgia oncológica, com foco em casos de tumores complexos nos Hospitais Büyük Anadolu.

• Especialista em cirurgias de pâncreas, ductos biliares e tumores adrenais
• Especialista em técnicas tradicionais e minimamente invasivas
• Realizar cirurgias de cancro da mama, gástrico e do cólon

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Especialização em Radio-oncologia na Universidade de Marmara – formação focada em tratamentos avançados de tumores adrenais.

• Mais de 6 anos de experiência especializada em radio-oncologia
• Graduado pela Faculdade de Medicina da Universidade de Marmara (programa em inglês)
• Trabalha no Hospital Emsey, uma instituição de referência em cuidados oncológicos

Com mais de 40 anos em otorrinolaringologia e cirurgia de cabeça e pescoço, o Dr. Ozdemir traz ampla experiência para casos de tumores adrenais.

• Graduar-se pela Universidade Hacettepe - uma das principais faculdades de medicina da Turquia
• Ex-chefe do Departamento de Otorrinolaringologia da Universidade Namik Kemal
• Serviço militar como especialista em otorrinolaringologia em Ancara
• Membro docente de longa data no Hospital de Formação e Investigação Izmir Atatürk

O Dr. Chaitainya Borde realizou mais de 30.000 exames de PET e tratou 1.000 pacientes com cancro da tiroide no HCG Manavata Cancer Centre.

• 12 anos de experiência em medicina nuclear
• Especializar-se em terapias de radioiodo e Lu-177 RN
• Ser proficiente em todos os tipos de exames nucleares e PET-CT
• Autor publicado em revistas médicas

Mais de 50.000 cirurgias oncológicas realizadas – O Dr. Raj traz mais de 19 anos de experiência no HCG Manavata Cancer Centre.

• Formado em Oncologia Cirúrgica no Tata Memorial Hospital
• Especializado em Oncologia Cirúrgica de Mama e Tórax
• Professor de subespecialidade DNB em Oncologia Cirúrgica
• Envolvido em mais de 200 ensaios clínicos

A Dra. Shruti Kate é especialista no tratamento de tumores adrenais, com foco em imunoterapia e terapia metronómica para cancros avançados. Formou-se no Tata Memorial Hospital, um dos principais centros de oncologia da Índia.

• DM em Oncologia Médica pelo Tata Memorial Hospital
• Especialista em cancros do pulmão, da mama e geniturinários
• Membro da ASCO, ESMO e outras sociedades oncológicas de prestígio
• Apresentar investigações na Conferência Mundial sobre o Cancro do Pulmão

Prof. Filippini especializa-se no tratamento cirúrgico de tumores localmente avançados e ressecções multiórgãos, com formação nos principais centros dos EUA, como o Memorial Sloan Kettering.

• Mais de 40 anos de experiência em cirurgia oncológica
• Formado em técnicas minimamente invasivas e robóticas nos EUA
• Autor de mais de 100 publicações científicas
• Professor na Universidade de Chieti desde a década de 1990

O Dr. Cubillo Gracián combina um vasto ensino em oncologia com o atendimento direto ao paciente no HM Sanchinarro.

• Dirigir a investigação de pós-graduação em oncologia clínica e aplicada
• Ensinar estudantes de medicina e residentes em práticas oncológicas
• Especializar-se em patologia do sistema digestivo e oncologia
• Liderar cursos sobre nutrição e avanços no cancro

O Prof. Engin traz décadas de experiência em radioncologia, incluindo uma prestigiada bolsa na Thomas Jefferson University, nos EUA.

• Mais de 30 anos de especialização no tratamento do cancro
• Formado no National Cancer Institute, nos EUA
• Ex-Presidente de Radioncologia na Universidade de Uludağ
• Diretor atual de Ciências Oncológicas na Medicana Bursa
• Membro das principais organizações de oncologia